4/17
04:30 am
bcrx
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency
Low
Report
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency
4/16
06:29 pm
bcrx
Pint Pharma Announces the Approval of ORLADEYO® (berotralstat), the First Oral Therapy Indicated for Preventing Hereditary Angioedema (HAE) Attacks in Adult and Pediatric Patients Aged 12 and Older in Brazil [Yahoo! Finance]
Low
Report
Pint Pharma Announces the Approval of ORLADEYO® (berotralstat), the First Oral Therapy Indicated for Preventing Hereditary Angioedema (HAE) Attacks in Adult and Pediatric Patients Aged 12 and Older in Brazil [Yahoo! Finance]
4/10
08:05 am
bcrx
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Low
Report
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
4/3
07:00 am
bcrx
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/25
04:01 pm
bcrx
BioCryst to Present at Upcoming Investor Conferences
Low
Report
BioCryst to Present at Upcoming Investor Conferences
3/5
07:01 am
bcrx
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/28
10:59 am
bcrx
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/27
09:14 am
bcrx
BioCryst's Revenue Gains Offset By Rising Expenses: A Closer Look [Seeking Alpha]
Neutral
Report
BioCryst's Revenue Gains Offset By Rising Expenses: A Closer Look [Seeking Alpha]
2/27
05:23 am
bcrx
BioCryst Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations [Yahoo! Finance]
Medium
Report
BioCryst Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations [Yahoo! Finance]
2/26
04:55 pm
bcrx
BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/26
07:45 am
bcrx
BioCryst Pharmaceuticals Inc (BCRX) Reports Growth in ORLADEYO Revenue and Projects ... [Yahoo! Finance]
Low
Report
BioCryst Pharmaceuticals Inc (BCRX) Reports Growth in ORLADEYO Revenue and Projects ... [Yahoo! Finance]
2/26
07:07 am
bcrx
BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones [Yahoo! Finance]
Medium
Report
BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones [Yahoo! Finance]
2/26
07:00 am
bcrx
BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones
Low
Report
BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones
2/23
07:10 am
bcrx
BioCryst Presents New Real-world Data Showing Rapid, Substantial and Sustained HAE Attack Rate Reductions After Beginning ORLADEYO® (berotralstat) Treatment [Yahoo! Finance]
Medium
Report
BioCryst Presents New Real-world Data Showing Rapid, Substantial and Sustained HAE Attack Rate Reductions After Beginning ORLADEYO® (berotralstat) Treatment [Yahoo! Finance]
2/23
07:00 am
bcrx
BioCryst Presents New Real-world Data Showing Rapid, Substantial and Sustained HAE Attack Rate Reductions After Beginning ORLADEYO® (berotralstat) Treatment
Low
Report
BioCryst Presents New Real-world Data Showing Rapid, Substantial and Sustained HAE Attack Rate Reductions After Beginning ORLADEYO® (berotralstat) Treatment
2/21
04:18 pm
bcrx
BioCryst to Present at Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
BioCryst to Present at Upcoming Investor Conferences [Yahoo! Finance]
2/21
04:01 pm
bcrx
BioCryst to Present at Upcoming Investor Conferences
Medium
Report
BioCryst to Present at Upcoming Investor Conferences
2/19
08:07 am
bcrx
BioCryst Launches ORLADEYO® (berotralstat) in Italy [Yahoo! Finance]
Low
Report
BioCryst Launches ORLADEYO® (berotralstat) in Italy [Yahoo! Finance]
2/19
07:54 am
bcrx
BioCryst Launches ORLADEYO® (berotralstat) in Italy
Low
Report
BioCryst Launches ORLADEYO® (berotralstat) in Italy
2/12
07:00 am
bcrx
BioCryst to Report Fourth Quarter 2023 Financial Results on February 26
Low
Report
BioCryst to Report Fourth Quarter 2023 Financial Results on February 26
2/5
07:20 am
bcrx
BioCryst to Present New ORLADEYO® (berotralstat) Real-world Data at 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting [Yahoo! Finance]
Low
Report
BioCryst to Present New ORLADEYO® (berotralstat) Real-world Data at 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting [Yahoo! Finance]
2/5
07:00 am
bcrx
BioCryst to Present New ORLADEYO® (berotralstat) Real-world Data at 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting
Low
Report
BioCryst to Present New ORLADEYO® (berotralstat) Real-world Data at 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting
2/2
07:00 am
bcrx
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/23
02:36 pm
bcrx
Ionis' (IONS) Donidalorsen Meets Late-Stage HAE Study Goal [Yahoo! Finance]
Low
Report
Ionis' (IONS) Donidalorsen Meets Late-Stage HAE Study Goal [Yahoo! Finance]